New research finds that exposure to odorant-based HDAC inhibitors could delay neurological disease onset

Imagine if we could inhale scents that delay the onset of cancer, inflammation, or neurodegenerative disease. Researchers at the University of California, Riverside, are poised to bring this futuristic technology closer to reality.